Key facts
- This page summarizes Stephen K. Brannan's Form 4 filing for Serina Therapeutics, Inc. (SER).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Jul 2026, 12:05.
Stephen K. Brannan - 07 Jul 2026 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)
- Reporting relationship
- Director
- Issuer ticker
- SER
- Reported as of
- 07 Jul 2026
- Net transaction value
- +$2,030
- SEC form
- 4
- Accepted by SEC
- 09 Jul 2026, 12:05:12 UTC
- Prior SEC filing
- 22 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Steven Ledger, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Stephen K. Brannan filed Form 4 for Serina Therapeutics, Inc. (SER) on 09 Jul 2026.
Change
- Previous filing in this sequence was filed on 22 Jun 2026.
- Current net transaction value: +$2,030.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001777631
Primary reporting owner
Brannan Stephen K.
- Relationship
- Director
- Address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE
- Signature
- /s/ Steven Ledger, Attorney in Fact
- Signature date
- 09 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SER
transaction
Common Stock
Purchase
- Transaction value
- $2,030
- Shares
- +1,000
- Change %
- Price
- $2.03
- Shares after
- 1,000
- Date
- 07 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.